Effects of low to moderate acute doses of pramipexole on impulsivity and cognition in healthy volunteers.

Journal of Clinical Psychopharmacology
Ajna HamidovicHarriet de Wit

Abstract

The neurotransmitter dopamine is integrally involved in the rewarding effects of drugs, and it has also been thought to mediate impulsive behaviors in animal models. Most of the studies of drug effects on impulsive behaviors in humans have involved drugs with complex actions on different transmitter systems and different receptor subtypes. The present study was designed to characterize the effect of single doses of pramipexole, a D2/D3 agonist, on measures of cognitive and impulsive behavior, as well as on mood in healthy volunteers. Healthy men and women (N = 10) received placebo and 2 doses of pramipexole, 0.25 and 0.50 mg, in a within-subject, double-blinded study. Outcome measures included changes in cognitive performance, assessed by the Automated Neuropsychological Assessment Metrics, several behavioral measures related to impulsive behavior, including the Balloon Analogue Risk Task, Delay Discounting Task, Go/No-Go Task, Card Perseveration Task, and subjective ratings of mood assessed by Addiction Research Center Inventory, Profile of Mood States, and Drug Effects Questionnaire. Pramipexole decreased positive ratings of mood (euphoria, intellectual efficiency, and energy) and increased both subjectively reported sedation...Continue Reading

References

Jun 1, 1991·Drug and Alcohol Dependence·H de Wit, R R Griffiths
Sep 1, 1987·The American Journal of Psychiatry·H R Lesieur, S B Blume
Jan 1, 1985·Psychopharmacology·L D ChaitC E Johanson
Jan 1, 1980·Psychopharmacology·C E Johanson, E H Uhlenhuth
Jun 23, 1995·European Journal of Pharmacology·J MierauR M Huff
Nov 1, 1995·Journal of Clinical Psychology·J H PattonE S Barratt
Apr 30, 1999·Journal of the Experimental Analysis of Behavior·J B RichardsH de Wit
Aug 26, 1999·Drug and Alcohol Dependence·N M Petry, T Casarella
Sep 24, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·H H Fernandez, J H Friedman
Dec 22, 1999·Addiction·F VitaroR E Tremblay
Nov 15, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Harriet de WitJerry B Richards
Dec 17, 2002·Proceedings of the National Academy of Sciences of the United States of America·Kevin J BlackJoel S Perlmutter
Dec 17, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·David C LottHarriet de Wit
Mar 7, 2006·Journal of Psychiatric Research·Janine D FloryStephen B Manuck
Mar 7, 2006·Pharmacology, Biochemistry, and Behavior·Brady ReynoldsHarriet de Wit
Apr 12, 2007·Expert Review of Neurotherapeutics·Jud A Staller, Stephen V Faraone
May 18, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Roshan CoolsMark D'Esposito
May 26, 2007·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Eliza CongdonTurhan Canli

❮ Previous
Next ❯

Citations

Jun 10, 2009·Psychopharmacology·Neal R SwerdlowJo A Talledo
Oct 17, 2009·Psychopharmacology·Arnt F A SchellekensR J Verkes
Oct 20, 2009·Psychopharmacology·Valerie VoonMark Hallett
Sep 4, 2010·Psychopharmacology·Patrick S JohnsonStephen C Fowler
Jun 25, 2013·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Shinichiro NakajimaAriel Graff-Guerrero
Jun 11, 2008·Experimental and Clinical Psychopharmacology·Matthew W Johnson, Warren K Bickel
Jun 16, 2010·Experimental and Clinical Psychopharmacology·Gregory J MaddenStephen C Fowler
Feb 1, 2012·Experimental and Clinical Psychopharmacology·Patrick S JohnsonJeffrey S Stein
Nov 27, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Naomi A FinebergEric Hollander
Oct 1, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Robert D Rogers
Oct 29, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Daniel Campbell-MeiklejohnRobert D Rogers
Apr 9, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·James David JentschEmanuele Seu
Jan 20, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sandra L Rokosik, T Celeste Napier
Sep 11, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Thilo van EimerenAntonio P Strafella
Jun 23, 2011·Behavioural Pharmacology·Mikhail N KoffarnusJames H Woods
Aug 9, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Agnes NorburyMasud Husain
Jul 2, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Alex PineRaymond J Dolan
Jun 29, 2011·Neuropsychiatry·Robert F Leeman, Marc N Potenza
Jan 19, 2016·Frontiers in Pharmacology·Clément E LemercierZoltan Gerevich
Feb 3, 2016·Journal of Cognitive Neuroscience·Karin FoerdeDaphna Shohamy
Nov 17, 2009·Biological Psychiatry·Christoph EiseneggerErnst Fehr
Aug 8, 2009·Pharmacology, Biochemistry, and Behavior·James P Zacny, Harriet de Wit
Mar 18, 2011·British Journal of Pharmacology·Catharine A Winstanley
Feb 26, 2013·Journal of the Experimental Analysis of Behavior·Patrick S JohnsonGregory J Madden
Mar 25, 2014·Annals of the New York Academy of Sciences·J David JentschZachary T Pennington
Nov 13, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Gabriel RobertOlivier Blin
Jul 5, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Isabelle BoileauDoris Payer
Nov 28, 2012·Drug and Alcohol Dependence·Tom P FreemanH Valerie Curran
May 1, 2012·Neuroscience·J W Dalley, J P Roiser
Sep 4, 2012·Neurobiology of Disease·Michel EngelnPierre-Olivier Fernagut
Nov 20, 2012·Pharmacology, Biochemistry, and Behavior·Katherine K RyanAlexandra S Potter
Oct 1, 2014·Journal of Autism and Developmental Disorders·Nathan A CallMindy C Scheithauer
Feb 15, 2014·Social Cognitive and Affective Neuroscience·Tom P FreemanH Valerie Curran
Nov 3, 2016·Frontiers in Human Neuroscience·Xue Qing YangPenny A MacDonald
Oct 20, 2012·Journal of the International Neuropsychological Society : JINS·Alison C SimioniLesley K Fellows
Jul 21, 2015·PloS One·Sarah A EisensteinTamara Hershey
Nov 19, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Eva MartinezLéon Tremblay
Dec 22, 2009·Expert Review of Medical Devices·Rodrigo C L EdelmuthFelipe Fregni

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.